Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quercetin. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1261585C enables high-purity isoquercetin via enzymatic hydrolysis. Offers cost reduction and scalable supply for nutraceutical and pharmaceutical manufacturing.
Patent CN107033113B reveals water-based chromatography for >99% purity quercetin, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel synthesis route from Rutin improves bioavailability and anti-tumor activity. Cost-effective manufacturing for global supply chains.
Patent CN111995607A details a novel aqueous synthesis for phenyl selenized luteolin and quercetin, offering scalable antiviral intermediate production with reduced costs.
Patent CN111995606B reveals a novel aqueous nucleophilic substitution for 7-methyl ketone luteolin and quercetin, offering significant cost reduction and scalable manufacturing.
Patent CN111995608A details a novel C-O coupling method for luteolin-quercetin dimers. Discover cost-effective manufacturing and high-purity antiviral intermediates.
Advanced chemical synthesis of Quercetin-3-O-acyl esters via patented benzylation and esterification routes. Offers superior bioavailability and scalable manufacturing for pharmaceutical applications.
Novel three-step synthesis of Dihydroquercetin offers high purity and scalability. Ideal for pharmaceutical intermediates supply chain optimization and cost reduction.
Patent CN109879847B reveals a scalable base-catalyzed deuteration method for flavonoids like baicalein and quercetin, offering improved metabolic stability for API development.
Patent CN102070592B reveals a scalable THP-protection route for dihydroquercetin. Discover cost reduction in pharmaceutical intermediates manufacturing and high-purity supply solutions.
Patent CN101638424A details novel astilbin derivatives enhancing solubility. Discover cost-effective synthesis routes for high-purity pharmaceutical intermediates.
Patent CN113185485A reveals a novel thiourea dioxide reduction method for dihydroquercetin, offering significant cost reduction and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN108047271B details a novel Cu-catalyzed synthesis of quercetin dimers. Discover cost-effective manufacturing and supply chain advantages for high-purity API intermediates.
Novel quercetin derivative synthesis improves bioavailability. High purity yield offers cost reduction in pharmaceutical intermediates manufacturing.